| Friday December 1, 2017 |
| 08:00 | Registration |
|
| 08:50 | Opening |
Prof Piet HERDEWIJN
(KU LEUVEN, Leuven, Belgium) |
| 09:00 | PL01 - 2’-Spiro-substituted Nucleosides Active against the Hepatitis C-virus |
Dr Tim JONCKERS
(JANSSEN, Beerse, Belgium) |
| 09:50 | PL02 - Use of Cyclic Dinucleotides (CDNs) to Induce Stimulator of Interferon Genes (STING)-Dependent Antitumor Immunity |
Dr Cedric BOULARAN
(INVIVOGEN, Toulouse, France) |
| 10:40 | Coffee break and Exhibition |
|
| 11:15 | OC01 - Unlock your Compound Management |
Dr Jan BREITENFELD
(CHEMSPEED TECHNOLOGIES AG, Füllinsdorf, Switzerland) |
| 11:35 | PL03 - Discovery of Novel DOT1L Inhibitors by Fragment Growing, Defragmentation and Fragment Linking |
Dr Henrik MÖBITZ
(NOVARTIS, Basel, Switzerland) |
| 12:25 | Lunch, Exhibition and Poster session |
|
| 14:00 | PL04 - Antitumoral and Antiviral Nucleosides, siRNAs and shRNAs for Applications in vitro, in vivo and in Bioprinted 3D Organ Models |
Prof. Jens KURRECK
(UNIVERSITY OF BERLIN, Berlin, Germany) |
| 14:50 | OC02 - Novel 3'-Deoxy Purine Nucleoside Analogs as Highly Potent Leads for Human African Trypanosomiasis |
Dr Fabian HULPIA
(UGENT, Beerse, Belgium) |
| 15:10 | OC03 - New Genetic Systems with Four Non-Canonical Nucleobases: Biotechnology and Therapeutic Applications |
Dr Elena EREMEEVA
(KU LEUVEN, Leuven, Belgium) |
| 15:30 | Coffee break, Exhibition and Poster session |
|
| 16:05 | PL05 - Synthetic Genetics: Beyond DNA and RNA |
Dr Philipp HOLLIGER
(MRC LABORATORY OF MOLECULAR BIOLOGY, Cambridge, United Kingdom) |
| 16:55 | PL06 - Large Scale Pooled Crispr Screening: Mining for the Deep |
Dr Roderick BEIJERSBERGEN
(NETHERLANDS CANCER INSTITUTE, Amsterdam, The Netherlands) |
| 17:45 | Closing Remarks |
|
